Search by category - Any -Regulated informationInside informationNon-regulated information Search by year - Any -202620252024202320222021202020192018201720162015 10 January 2018 Disclosure of a transparency notification (Article 14, paragraph 1 of the Belgian Act of 2 May 2007 on disclosure of major shareholdings) Regulated information 9 January 2018 Disclosure of a transparency notification (Article 14, paragraph 1 of the Belgian Act of 2 May 2007 on disclosure of major shareholdings) Regulated information 9 January 2018 Biocartis and Amgen Sign New Companion Diagnostic Agreement for Novel Oncology Compound Non-regulated information 22 December 2017 Disclosure of Outstanding Voting Securities Regulated information 6 December 2017 Disclosure of a transparency notification (Article 14, paragraph 1 of the Belgian Act of 2 May 2007 on disclosure of major shareholdings) Regulated information 4 December 2017 Biocartis and Amgen Sign Companion Diagnostic Agreement for Idylla™ RAS Biomarker Tests Agreement aims to deliver faster biomarker results to realize more informed treatment decisions Non-regulated information 27 November 2017 Biocartis launches CE-marked IVD RAS liquid biopsy tests developed under partnership with Merck KGaA, Darmstadt, Germany The Idylla™ ctRAS liquid biopsy tests detect RAS mutations in patients with metastatic colorectal cancer Non-regulated information 16 November 2017 Biocartis Q3 2017 Business Update Regulated information 15 November 2017 Idylla™ Performance Data Presented by US Key Opinion Leaders at Association for Molecular Pathology 2017 Conference Non-regulated information 14 November 2017 Disclosure of a transparency notification (Article 14, paragraph 1 of the Belgian Act of 2 May 2007 on disclosure of major shareholdings) Regulated information Pagination First page « First Previous page ‹‹ … Page 20 Page 21 Page 22 Page 23 Current page 24 Page 25 Page 26 Page 27 Page 28 … Next page ›› Last page Last »